Effects of Gamitaeeumjowee-tang for Weight Loss in Overweight and Obese Shift Workers: A Retrospective Chart Review

Article information

J Korean Med. 2025;46(3):1-15
Publication date (electronic) : 2025 September 1
doi : https://doi.org/10.13048/jkm.25030
1Nubebe Korean Medical Clinic Bundang Center
2Nubebe Obesity Research Institute
Correspondence to: Eunjoo Kim, Nubebe Korean Medical Clinic Bundang Center, 10 Seongnam-daero, 926beon-gil, Bundang-gu, Seongnam 13506, Korea, Tel:+82-31-702-0045, Fax:+82-31-701-8993, E-mail:boggil82@gmail.com
§

These authors contributed equally to this work.

Received 2025 May 30; Revised 2025 July 15; Accepted 2025 August 12.

Abstract

Objectives

This study aimed to evaluate the weight loss effects and safety of Gamitaeeumjowee-tang in overweight and obese shift workers through a retrospective chart review.

Methods

A total of 27 shift workers with a body mass index (BMI) ≥23 kg/m2 who visited a Korean medicine obesity clinic for weight loss were included. Participants took Gamitaeeumjowee-tang for 12 weeks. Changes in body weight, body composition, blood pressure, and adverse events were assessed and compared with a control group of 33 non-shift workers.

Results

After 12 weeks of treatment, the shift worker group showed a significant reduction in body weight (6.63±3.37 kg, P<0.05), body fat mass (6.13±2.96 kg, P<0.05), BMI (2.52±1.28 kg/m2, P<0.05), and body fat rate (5.23 ± 3.18%p, P<0.05) along with a significant increase in skeletal muscle rate (2.92 ± 1.74%p, P<0.05). There were no significant differences in weight loss and body composition changes between the shift worker group and the non-shift worker group. When evaluating changes in blood pressure and pulse, only systolic blood pressure significantly decreased in the shift worker group (P=0.041). Most adverse events were mild, and no serious adverse reactions were reported.

Conclusions

Gamitaeeumjowee-tang appears to be a safe and effective option for weight management in overweight and obese shift workers without causing serious adverse events.

Fig. 1

Flow chart of dataset for analysis.

Composition of Gamitaeeumjowee-tang

Baseline Characteristics of Patients

Variable Changes Comparison between two groups

Changes in Blood Pressure and Pulse rate

Comparison of Categorical Variables between Shift workers and Not Shift workers

Adverse Events Reported from 60 Patients using Gamitaeeumjowee-tang

Adverse Events According to System Organ Classes

References

1. Ministry of Employment and Labor. Guidelines for application of Labor Standards Act to shift workers Seoul (KR): Ministry of Employment and Labor; 2008. Mar.
2. Jang S. Y., Park S. B.. The effect of shift-work on quality of life (EQ-5D). Korean J Health Econ Policy 2015;21(2):1–25.
3. Korea Occupational Safety and Health Agency. 7th Korean Working Conditions Survey Seoul (KR): KOSHA; 2023. Nov. p. 38.
4. Lee J., Lee Y.. 2012;In a 24-hour society. Radical Rev (54):59–279.
5. Kim Y. A., Kim H. H., Lim D. H.. 2018;Association of work hours with metabolic syndrome among shift workers: mediating effects of diet, nutrition, and daily habits. J Nutr Health 51(6):567–579.
6. Proper K. I., van de Langenberg D., Rodenburg W., Vermeulen R. C. H., van der Beek A. J., van Steeg H., van Kerkhof L. W. M.. 2016;The Relationship Between Shift Work and Metabolic Risk Factors: A Systematic Review of Longitudinal Studies. American journal of preventive medicine 50(5):e147–e157. https://doi.org/10.1016/j.amepre.2015.11.013.
7. Chen J. D., Lin Y. C., Hsiao S. T.. 2010;Obesity and high blood pressure of 12-hour night shift female clean-room workers. Chronobiology international 27(2):334–344. https://doi.org/10.3109/07420520903502242.
8. Hansen A. B., Stayner L., Hansen J., Andersen Z. J.. 2016;Night shift work and incidence of diabetes in the Danish Nurse Cohort. Occupational and environmental medicine 73(4):262–268. https://doi.org/10.1136/oemed-2015-103342.
9. Park S., Nam J., Lee J. K., Oh S. S., Kang H. T., Koh S. B.. 2015;Association between night work and cardiovascular diseases: analysis of the 3rd Korean working conditions survey. Annals of occupational and environmental medicine 27:15. https://doi.org/10.1186/s40557-015-0064-1.
10. Vetter C., Devore E. E., Wegrzyn L. R., Massa J., Speizer F. E., Kawachi I., Rosner B., Stampfer M. J., Schernhammer E. S.. 2016;Association Between Rotating Night Shift Work and Risk of Coronary Heart Disease Among Women. JAMA 315(16):1726–1734. https://doi.org/10.1001/jama.2016.4454.
11. Kim J. M., Suh B. S., Jung K. Y., Kim D. I., Kim W. S., Cho H. S., et al. 2017;The study for musculoskeletal symptoms and job stress in firemen. J Korean Soc Occup Environ Hyg 17(2):111–119.
12. Lee Y., Lee W.. 2024;Shift work and non-alcoholic fatty liver disease in young, healthy workers. Scientific reports 14(1):19367. https://doi.org/10.1038/s41598-024-70538-9.
13. Morgan P. J., Collins C. E., Plotnikoff R. C., Cook A. T., Berthon B., Mitchell S., Callister R.. 2011;Efficacy of a workplace-based weight loss program for overweight male shift workers: the Workplace POWER (Preventing Obesity Without Eating like a Rabbit) randomized controlled trial. Preventive medicine 52(5):317–325. https://doi.org/10.1016/j.ypmed.2011.01.031.
14. Phoi Y. Y., Keogh J. B.. 2019;Dietary Interventions for Night Shift Workers: A Literature Review. Nutrients 11(10):2276. https://doi.org/10.3390/nu11102276.
15. Lee Y. H., Kwon G. S., Lee S. H., Lee E. S., Kim C. H., Jang K. J., et al. 2012;Clinical review of the effects of Samgi-Halleak herbal medicine on insomnia and fatigue. J Acupunct Res 29(3):101–113.
16. Wang S. T., Lin Y. K., Weng S. F., Huang C. L., Huang H. C., Chiu Y. C., Hu S.. 2020;Skeletal Muscle Ratio: A Complete Mediator of Physical Activity and HbA1C in Type 2 Diabetes. Biological research for nursing 22(4):536–543. https://doi.org/10.1177/1099800420942884.
17. World Health Organization-Uppsala Monitoring Centre (WHO-UMC). The use of the WHO-UMC system for standardized case causality assessment [Internet] 2018. [cited 2024 Jun 7]. Available from: https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf.
18. National Cancer Institute, National Institute of Health, U.S. Department of Health and Human Services. Common terminology criteria for adverse events (CTCAE) version 5.0 [Internet] 2017. [cited 2025 May 5] https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf.
19. Korea Institute of Drug Safety & Risk Management. Terminology guide for reporting adverse drug reactions Seoul (KR): KIDS; 2014. p. 1–6.
20. Korean Endocrine Society. Korean Society for the Study of Obesity. Management of obesity: 2010 recommendation. Endocrinol Metab 2010;25:301–304.
21. Korean Obesity Association. Treatment Guideline for Obesity Seoul (KR): Korean Obesity Association; 2024.
22. Lee J. M.. Longevity and life preservation in Eastern medicine Seoul (KR): Haklimsa; 1986. p. 333–338.
23. Lee A. R., Lee D. Y., Kim M. J., Lee H. S., Choi K. H., Kim S. Y., et al. 2021;Gamitaeeumjowee-tang for weight loss in diabetic patients: a retrospective chart review. J Korean Med 42(1):46–58. https://doi.org/10.13048/jkm.21004.
24. Kim M. J., Won B. Y., Kim H. J., Choi K. H.. 2023;Clinical Application of Gamitaeeumjowee-tang for Overweight or Obese Hypothyroidism Patients: A Retrospective Chart Review. J Korean Med Obes Res 23(2)https://doi.org/10.15429/jkomor.2023.23.2.78.
25. Lee Y. J., Kang J. I., Kim Y. H., Min E. C., Lim Y. W., Kim E.. 2024;Gamitaeeumjowee-tang for weight loss in post-menopausal obese women: a retrospective chart review. J Korean Med 45(1):64–78. https://doi.org/10.13048/jkm.24004.
26. Kang J. I., Kim Y. H., Lee Y., Lim Y. W., Kim E.. 2024;Gamitaeeumjowee-tang for Weight Loss in Postpartum Overweight and Obese Women: A Retrospective Chart Review. J Korean Med Obes Res 24(2):157–165. https://doi.org/10.15429/jkomor.2024.24.2.157.
27. Park Y. J., Cominguez D. C., Kim H. J., Jin J. S., Koh D. J., Kim S. Y., Lim Y. W., Park Y. B., An H. J.. 2021;Therapeutic effects of Gambi-jung for the treatment of obesity. Biomed Pharmacother 141:111838. https://doi.org/10.1016/j.biopha.2021.111838.
28. Stohs S. J., Shara M., Ray S. D.. 2020;p-Synephrine, ephedrine, p-octopamine and m-synephrine: Comparative mechanistic, physiological and pharmacological properties. Phytotherapy research : PTR 34(8):1838–1846. https://doi.org/10.1002/ptr.6649.
29. Quer G., Gouda P., Galarnyk M., Topol E. J., Steinhubl S. R.. 2020;Inter-and intraindividual variability in daily resting heart rate and its associations with age, sex, sleep, BMI, and time of year: Retrospective, longitudinal cohort study of 92,457 adults. Plos one 15(2):e0227709. https://doi.org/10.1371/journal.pone.0227709.
30. Park S., Park M. J., Kim E., Kim E., Lim Y. W.. 2024;The Effect of Taking Gamitaeeumjowee-tang for 2 Weeks on Blood Pressure, Pulse Rate and Body Weight in Overweight or Obese Patients: A Retrospective Chart Review. Journal of Korean Medicine for Obesity Research 24(1):68–75. https://doi.org/10.15429/jkomor.2024.24.1.68.
31. Knell G., Li Q., Pettee Gabriel K., Shuval K.. 2018;Long-Term Weight Loss and Metabolic Health in Adults Concerned With Maintaining or Losing Weight: Findings From NHANES. Mayo Clinic proceedings 93(11):1611–1616. https://doi.org/10.1016/j.mayocp.2018.04.018.
32. Bae M. J., Song Y. M., Shin J. Y., Choi B. Y., Keum J. H., Lee E. A.. 2017;The Association Between Shift Work and Health Behavior: Findings from the Korean National Health and Nutrition Examination Survey. Korean journal of family medicine 38(2):86–92. https://doi.org/10.4082/kjfm.2017.38.2.86.
33. Ko S. B.. 2013;Night Shift Work, Sleep Quality, and Obesity. Journal of lifestyle medicine 3(2):110–116.
34. AlMetrek M.. 2014;Effect of shift-work on sleeping quality of male factory workers in Saudi Arabia. National Journal of Physiology Pharmacy and Pharmacology 4(1):61–68. 10.5455/njppp.2014.4.100820131.
35. van Mark A., Weiler S. W., Schröder M., Otto A., Jauch-Chara K., Groneberg D. A., Spallek M., Kessel R., Kalsdorf B.. 2010;The impact of shift work induced chronic circadian disruption on IL-6 and TNF-alpha immune responses. Journal of occupational medicine and toxicology (London, England) :5–18. https://doi.org/10.1186/1745-6673-5-18.
36. Ahn Y. E.. 2021;Influences of Physical Symptoms, Sleep Quality, Fatigue and Health Promoting Behaviors on Job Satisfaction of Shift Nurses. STRESS 29(4):262–270.
37. Jeong I. K.. 2012;The role of cortisol in the pathogenesis of the metabolic syndrome. Diabetes & metabolism journal 36(3):207–210. https://doi.org/10.4093/dmj.2012.36.3.207.
38. Van Cauter E., Holmback U., Knutson K., Leproult R., Miller A., Nedeltcheva A., Pannain S., Penev P., Tasali E., Spiegel K.. 2007;Impact of sleep and sleep loss on neuroendocrine and metabolic function. Hormone research 67(Suppl 1):2–9. https://doi.org/10.1159/000097543.
39. Lee M. J., Park Y. B., Lim Y. W., Kim S. Y.. 2020;The association between sleep and weight loss among adult women with obesity administered with Gamitaeeumjowee-tang. J Korean Med 41(3):22–31. https://doi.org/10.13048/jkm.20023.
40. Souza R. V., Sarmento R. A., de Almeida J. C., Canuto R.. 2019;The effect of shift work on eating habits: a systematic review. Scandinavian journal of work, environment & health 45(1):7–21. https://doi.org/10.5271/sjweh.3759.
41. Han K., Choi-Kwon S., Kim K. S.. 2016;Poor dietary behaviors among hospital nurses in Seoul, South Korea. Applied nursing research : ANR 30:38–44. https://doi.org/10.1016/j.apnr.2015.10.009.
42. Richter K., Peter L., Rodenbeck A., Weess H. G., Riedel-Heller S. G., Hillemacher T.. 2021;Shiftwork and Alcohol Consumption: A Systematic Review of the Literature. European addiction research 27(1):9–15. https://doi.org/10.1159/000507573.
43. Baik I.. 2018;Forecasting obesity prevalence in Korean adults for the years 2020 and 2030 by the analysis of contributing factors. Nutrition research and practice 12(3):251–257. https://doi.org/10.4162/nrp.2018.12.3.251.
44. Chang A. K., Choi J. Y.. 2015;Factors influencing BMI classifications of Korean adults. Journal of physical therapy science 27(5):1565–1570. https://doi.org/10.1589/jpts.27.1565.
45. Tosoratto J., Tárraga López P. J., López-González ÁA, Vallejos D., Martínez-Almoyna Rifá E., Ramirez-Manent J. I.. 2024;Association of Shift Work, Sociodemographic Variables and Healthy Habits with Obesity Scales. Life (Basel, Switzerland) 14(11):1503. https://doi.org/10.3390/life14111503.
46. Ha M., Park J.. 2005;Shiftwork and metabolic risk factors of cardiovascular disease. Journal of occupational health 47(2):89–95. https://doi.org/10.1539/joh.47.89.

Appendices

Appendix 1. Questionnaire on Lifestyle Habits

jkm-46-3-1-appendix-1.pdf

Article information Continued

Fig. 1

Flow chart of dataset for analysis.

Table 1

Composition of Gamitaeeumjowee-tang

Ingredient Dose(g)/day
Ephedra Herba 16.0~24.0
Rehmanniae Radix Preparat 8.0
Coicis Semen 8.0
Zingiberis Rhizoma Recens 4.0
Acori Gramineri Rhizoma 3.3
Zizyphi Semen 3.3
Alismatis Rhizoma 2.6
Scutellariae Radix 1.3
Schizandrae Fructus 1.3
Puerariae Radix 1.3
Asparagi Tuber 1.3
Angelicae Tenuissimae Radix 1.3
Longanae Arillus 1.3
Castanea Moliissima 1.3
Liriopis Tuber 1.3

Total amount 55.6~63.6

Table 2

Baseline Characteristics of Patients

Characteristics Total (n=60) Shift workers (N= 27) Not shift workers (N= 33) P-value
Age(year)* 36.82 ± 12.88 36.33 ± 11.70 37.21 ± 13.94 0.982
Weight (kg)* 75.60 ± 12.20 77.51 ± 14.02 74.04 ± 10.44 0.414
Body Fat mass (kg) 30.47 ± 6.65 30.64 ± 7.06 30.33 ± 6.41 0.858
Skeletal muscle mass(kg)* 24.77 ± 4.81 25.81 ± 5.79 23.92 ± 3.70 0.316
BMI (kg/m2 ) 28.87 ± 3.30 29.19 ± 3.73 28.62 ± 2.94 0.514
Systolic Blood Pressure (mmHg) 129.93 ± 10.96 132.67 ± 9.02 127.70 ± 12.00 0.080
Diastolic Blood Pressure (mmHg) 79.38 ± 10.16 80.26 ± 10.31 78.67 ± 10.15 0.550
Pulse (bpm) 84.05 ± 11.41 84.74 ± 10.51 83.48 ± 12.23 0.675

Data are expressed mean±standard deviation.

*

: Non-normally distributed data

Table 3

Variable Changes Comparison between two groups

Characteristics Shift workers (N= 27) Not shift workers (N= 33) P-value
Weight (kg) 6.63 ± 3.37* 6.69 ± 2.57* 0.858
Weight loss rate (%)) 8.69 ± 4.38* 9.30 ± 3.97* 0.629
Skeletal muscle mass (kg) 0.24 ± 1.00 0.54 ± 0.74* 0.100
Body Fat mass (kg) 6.13 ± 2.96* 5.78 ± 2.29* 0.606
BMI (kg/m2 ) 2.52 ± 1.28* 2.62 ± 1.05* 0.746
Skeletal muscle rate(%p) 2.92 ± 1.74* 2.51 ± 1.42* 0.326
Body fat rate (%p) 5.23 ± 3.18* 4.73 ± 2.59* 0.503

Data are expressed mean±standard deviation.

*

P<0.05,

paired t test or wilcoxon singed rank test / comparison within group before and after program

Table 4

Changes in Blood Pressure and Pulse rate

Initial value Final value P-value
Shift workers (N= 27) Systolic Blood Pressure (mmHg) 132.67 ± 9.02 127.3 ± 12.25 0.041*
Diastolic Blood Pressure (mmHg) 80.26 ± 10.31 78.70 ± 10.70 0.487
Pulse (bpm) 84.74 ± 10.51 91.48 ± 12.13 0.007*

Not shift workers (N= 33) Systolic Blood Pressure (mmHg) 127.70 ± 12.00 126.33 ± 11.64 0.561
Diastolic Blood Pressure (mmHg) 78.67 ± 10.15 78.82 ± 8.71 0.928
Pulse (bpm) 83.48 ± 12.23 95.24 ± 12.19 <.001*

Data are expressed mean±standard deviation.

*

P<0.05, paired t test.

Table 5

Comparison of Categorical Variables between Shift workers and Not Shift workers

Categorical variables Shift workers (N = 27) Not shift workers group (N = 33) P-value
Sleep regularity Regular 2 (7.4) 20 (60.6) <.001
Irregular 25 (92.6) 13 (39.4)

Dietary habits Meal regularity Regular 4 (14.8) 14 (42.4) 0.020
Irregular 23 (85.2) 19 (57.6)

Night time eating Yes 12 (44.4) 8 (24.2) 0.099
No 15 (55.6) 25 (75.8)

Light eating Yes 0 (0.0) 1 (3.0) 1.000
No 27 (100) 32 (97.0)
Binge eating Yes 11 (40.7) 12 (36.4) 0.729
No 16 (59.3) 21 (63.6)

Alcohol consumption frequency* 0 (week) 8 (30.8) 13 (39.4) 0.419
≤ 1 12 (46.2) 9 (27.3)
2–3 6 (23.1) 10 (30.3)
≥ 4 0 (0.0) 1 (3.0)

Physical activity level* < 1h 3 (11.5) 3 (9.1) 0.517
1–3 h 8 (30.8) 15 (45.5)
≥ 3 15 (57.7) 15 (45.5)

Weight loss experience Weight loss with drug 15 (55.6) 16 (48.5) 0.586
None 12 (44.4) 17 (51.5)

Data are expressed as number (%) for categorical variables.

*

: Chi-square test was conducted on 26 participants after excluding 1 missing value;

: Fisher’s Exact Test;

: P<0.05

Table 6

Adverse Events Reported from 60 Patients using Gamitaeeumjowee-tang

Shift workers (N= 27) Not shift workers (N= 33)

Variables 2–6 weeks 10–14 weeks 2–6 weeks 10–14 weeks
Causality (WHO-UMC)
 Possible 11 (25.6) 3 (20.0) 11 (16.2) 1 (4.5)
 Unlikely 32 (74.4) 12 (80.0) 57 (83.8) 21 (95.5)
 Conditional/unclassified 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Total 43 (100) 15 (100) 68 (100) 22 (100)

Severity (CTCAE v5.0)
 Mild (Grade1) 43 (100) 14 (93.3) 68 (100) 21 (95.5)
 Moderate (Grade 2) 0 (0.0) 1 (6.7) 0 (0.0) 1 (4.5)
 Severe (Grade 3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
 Total 43 (100) 15 (100) 68 (100) 22 (100)

Data are expressed number (%).

WHO-UMC; World Health Organization-Uppsala Monitoring Centre, CTCAE; Common Terminology Criteria for Adverse Events

Table 7

Adverse Events According to System Organ Classes

Shift workers (N= 27) Not shift workers (N= 33)

System-organ classes Symptom 2–6 weeks 10–14 weeks 2–6 weeks 10–14 weeks
Gastro-intestinal system disorders Constipation 7 (16.3) 6 (40.0) 10 (14.7) 6 (27.3)
Dyspepsia 0 (0.0) 0 (0.0) 2 (2.9) 0 (0.0)
Nausea 3 (7.0) 0 (0.0) 4 (5.9) 1 (4.5)
Vomiting 1 (2.3) 0 (0.0) 2 (2.9) 0 (0.0)
Heartburn 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)
Hemorrhoids 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)
Hematochezia 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)
Subtotal 11 (25.6) 6 (40.0) 21 (30.9) 7 (31.8)

Central & peripheral nervous system disorders Dizziness 2 (4.7) 0 (0.0) 7 (10.3) 3 (13.6)
Headache 6 (14.0) 1 (6.7) 6 (8.8) 1 (4.5)
Tremor 2 (4.7) 0 (0.0) 7 (10.3) 1 (4.5)
Paresthesia 1 (2.3) 0 (0.0) 0 (0.0) 0 (0.0)
Subtotal 11 (25.6) 1 (6.7) 20 (29.4) 5 (22.7)

Psychiatric disorders Insomnia 5 (11.6) 3 (20.0) 3 (4.4) 3 (13.6)
Subtotal 5 (11.6) 3 (20.0) 3 (4.4) 3 (13.6)

Autonomic nervous system disorders Dry mouth 2 (4.7) 1 (6.7) 6 (8.8) 2 (9.1)
Palpitation 4 (9.3) 1 (6.7) 6 (8.8) 0 (0.0)
Sweating increased 2 (4.7) 1 (6.7) 3 (4.4) 1 (4.5)
Subtotal 8 (18.6) 3 (20.0) 15 (22.1) 3 (13.6)

Body as a whole - general disorders Malaise 1 (2.3) 0 (0.0) 3 (4.4) 0 (0.0)
Feeling hot 2 (4.7) 0 (0.0) 1 (1.5) 0 (0.0)
Feeling cold 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)
Cold sweat 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)
Subtotal 3 (7.0) 0 (0.0) 6 (8.8) 0 (0.0)

Skin and appendages disorders Scalp pruritus 1 (2.3) 0 (0.0) 0 (0.0) 0 (0.0)
Subtotal 1 (2.3) 0 (0.0) 0 (0.0) 0 (0.0)

Urinary system disorders Urinary frequency 1 (2.3) 0 (0.0) 1 (1.5) 1 (4.5)
Dysuria 2 (4.7) 2 (13.3) 0 (0.0) 0 (0.0)
Subtotal 3 (7.0) 2 (13.3) 1 (1.5) 1 (4.5)

Reproductive disorders Menstrual irregularity 0 (0.0) 0 (0.0) 0 (0.0) 2 (9.1)
Menorrhagia 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)
Erectile dysfunction 1 (2.3) 0 (0.0) 0 (0.0) 0 (0.0)
Subtotal 1 (2.3) 0 (0.0) 1 (1.5) 2 (9.1)

Musculo-skeletal system disorders Myalgia 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)
Subtotal 0 (0.0) 0 (0.0) 1 (1.5) 0 (0.0)

Respiratory system disorders Hoarseness 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.5)
Subtotal 0 (0.0) 0 (0.0) 0 (0.0) 1 (4.5)

Total 43(100) 15(100) 68(100) 22(100)

Data are expressed number (%)